Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,415,234 | $2,650,942 | $2,945,696 | $2,502,146 |
| - Cash | $689,892 | $652,800 | $580,656 | $517,553 |
| + Debt | $2,461 | $2,991 | $3,091 | $3,188 |
| Enterprise Value | $1,727,803 | $2,001,133 | $2,368,131 | $1,987,781 |
| Revenue | $148,392 | $146,563 | $141,421 | $141,820 |
| % Growth | 1.2% | 3.6% | -0.3% | – |
| Gross Profit | $123,081 | $116,605 | $123,510 | $120,177 |
| % Margin | 82.9% | 79.6% | 87.3% | 84.7% |
| EBITDA | $80,451 | $78,753 | $72,827 | $72,301 |
| % Margin | 54.2% | 53.7% | 51.5% | 51% |
| Net Income | $52,783 | $52,108 | $56,737 | $55,936 |
| % Margin | 35.6% | 35.6% | 40.1% | 39.4% |
| EPS Diluted | 0.42 | 0.41 | 0.45 | 0.44 |
| % Growth | 2.4% | -8.9% | 2.3% | – |
| Operating Cash Flow | $32,438 | $71,298 | $60,043 | $70,877 |
| Capital Expenditures | $0 | -$26 | $0 | -$88 |
| Free Cash Flow | $32,438 | $71,272 | $60,043 | $70,789 |